Brian Tufts joined Ambient Clinical Analytics as Chief Executive Officer in March 2026 as a MedTech executive focused on transforming care in hospitals, bringing more than 25 years of experience across tech start-up and Fortune 500 companies. Prior to Ambient, Brian served as the Global Commercial Lead of Vantive’s Acute Therapies business, where he played an instrumental role in establishing Vantive as an independent vital organ therapy company through its private equity-backed carve-out from Baxter in 2025. He joined Baxter in 2008, progressing through roles of increasing responsibility across U.S. and global markets. Earlier in his career, Brian led sales and marketing at QuesTek Innovations. Brian served on the board of MiroMatrix (NASDAQ: MIRO) prior to its acquisition by United Therapeutics and continues to serve on the board of Solidarity Bridge, a nonprofit expanding surgical care access in South America. He holds a B.S. and M.S. in Materials Science Engineering from Northwestern University and an M.B.A. with distinction from the Kellogg School of Management.

Mr. Berning is an entrepreneur with over 20 years of experience managing technology start-ups. Mr. Berning was the CEO of Hardcore Computer/Liquid Cool Solutions from 2007 to 2012. Prior to Liquid Cool Solutions Mr. Berning was CEO and Chairman of the Board of PEMSTAR from its founding in 1994. Mr. Berning led PEMSTAR to an IPO on NASDAQ in 2000 and its merger with Benchmark Electronics. In the early part of his career, Mr. Berning held numerous positions in management and engineering at IBM. He has sat on numerous boards including the Greater Rochester Area University Center, United Way of Olmsted County and the Advisory and Advocacy Board of the University of Minnesota Rochester. Mr. Berning received his M.B.A. and B.S. in industrial engineering from St. Cloud University.

Mr. Kuebelbeck is a senior executive with more than 20 years of healthcare expertise in the areas of leadership, sales, marketing, and customer relations. Mr. Kuebelbeck brings extensive knowledge delivering solutions that improve the clinical experiences for providers and keeping patients safe while meeting critical quality and regulatory measures. Currently Mr. Kuebelbeck is responsible for marketing, revenue generation and solution sales aimed at improving patient safety, patient/provider satisfaction and financial performance through innovative solutions and services. Prior to Ambient Clinical, Mr. Kuebelbeck earned a B.I.S. in Management and Communications from the University of Minnesota and has held positions with LogicStream Health, Nant Health, HealthScribe, and IMNET / HBOC / McKesson.

Mr. Flaada has the responsibility for the product portfolio and technical direction and innovation for Ambient. He has 35 years of experience across IT, primarily as a technical executive at IBM. His experiences include both hardware and software development, spanning product management and technical leadership in enterprise software, high performance computing, cloud computing, and other core “new technology” areas. As part of these experiences Mr. Flaada led and managed a 10 year joint research and development collaboration between IBM and leading clinicians at Mayo Clinic in better applying information technology in clinical practice. Mr. Flaada has earned a BS in Electrical Engineering from North Dakota State University, and an MS in Management of Technology from the University of Minnesota. 

His interest in the area of medical informatics extends back to 1995 with a specific concentration on the applied clinical informatics in critical care. Dr. Herasevich has interests in studying and developing clinical syndromic surveillance, data visualization, decision support and prescriptive analytics. He is co-inventor of patented and licensed informatics technologies including AWARE and Sepsis DART, co-author of 90 PubMed cited articles book Health Information Evaluation Handbook. Dr. Herasevich teaches medical informatics classes at Mayo Medical School and Graduate School. He is a Fellow of Society of Critical Care Medicine and active within informatics societies serving on a number of committees.

Jessica Tam joined Ambient Clinical Analytics in May 2026 as Vice President, Strategy and Growth. Jessica brings almost a decade of experience in MedTech and digital health and is deeply rooted in the Midwest startup and venture community. Prior to Ambient, Jessica led the development and commercialization of several new product innovations at Baxter Healthcare, including products used for the assessment and treatment of patients with sepsis and septic shock, and has also held multiple corporate strategy roles focused on digital health and innovation. Jessica is also an advisor for 2Flo Ventures, a Chicago-based health equity venture fund. She received her B.S. in Chemical Engineering from Stanford University and her M.B.A from the University of Chicago Booth School of Business.